Kuehm, L. M., Wolf, K., Zahour, J., DiPaolo, R. J., & Teague, R. M. (2019). Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity. Cancer Immunol Immunother.
Styl ChicagoKuehm, Lindsey M., Kyle Wolf, John Zahour, Richard J. DiPaolo, a Ryan M. Teague. "Checkpoint Blockade Immunotherapy Enhances the Frequency and Effector Function of Murine Tumor-infiltrating T Cells but Does Not Alter TCRβ Diversity." Cancer Immunol Immunother 2019.
Citace podle MLAKuehm, Lindsey M., et al. "Checkpoint Blockade Immunotherapy Enhances the Frequency and Effector Function of Murine Tumor-infiltrating T Cells but Does Not Alter TCRβ Diversity." Cancer Immunol Immunother 2019.